Retraction of high-profile paper on cancer drug timing could hand ammo to China hawks - Endpoints News
- Retraction of high-profile paper on cancer drug timing could hand ammo to China hawks Endpoints News
- Nature retracts provocative PD-1 study that tied lung cancer survival to treatment timing Fierce Pharma
- Nature Medicine retracts Chinese lung cancer immunotherapy timing study 동아사이언스
- Paolo Tarantino: Nature Medicine Retracts Debated Study on Early Morning Immunotherapy Benefits Oncodaily
- Nature Retracts Cancer Study Suggesting Treatment Is Better Earlier in the Day MedPage Today
Related Markets
All MarketsMarket data may be delayed. Not financial advice.
💡 AI analysis provides alternative perspectives on current events